CClinicalTrials.gg
Status unknownNCT03757780Updated Jan 9, 2019

Low Birth Weight Fetuses With Caffeine Use

An observational study in Low; Birthweight, Extremely (999 Grams or Less), sponsored by Aljazeera Hospital. Status unknown at 1 site in Egypt. Open to female participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-01-09.

Sponsored by Aljazeera Hospital · Observational

The sponsor has not verified this record recently (last verified Jan 2019), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
500
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

Globally, it has been estimated that 15.5% of all infantsare born low birth weight, defined as birthweight less than 2,500 g .

Read the detailed description

Low birth weight is not only associated with neonatal mortality and morbidity.

but also with a higher risk of chronic diseases such as type 2 diabetes and cardiovascular diseases in adult life

02

Conditions studied

  • Low; Birthweight, Extremely (999 Grams or Less)

Browse trials for

03

In context

Birth Weight

445 studies on the registry are indexed under Birth Weight; 36 are open to participants now.

This study's planned enrollment of 500 is above the median of 212 across 136 observational studies indexed under Birth Weight.

Browse Birth Weight studies →

Lead sponsor

Aljazeera Hospital is the lead sponsor of 63 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Age group: 18-40

•Pregnant females attending regular post-natal care visits

Inclusion criteria

  • Age group: 18-40
  • Pregnant females attending regular post-natal care visits

Exclusion criteria

Exclusion Criteria:

    • Female patients with other acute or chronic illness

      • Cardiovascular disease
      • Neoplasms
      • Current diabetes mellitus, pregnancy induced diabetes
      • Renal impairment (serum creatinine 120 mol/liter), and hypertension (blood pressure 140/85 mm Hg).
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
500 participants (estimated)
Patient registry
No

Groups and cohorts

  • Pregnant ladies who are caffeine using

    ladies who uses caffeine during pregnancy

    Other: Questionaire

Interventions

  • OtherQuestionaire

    A questionaire will be made to pregnant ladies who take caffeine during pregnancy

06

What researchers measure

Primary outcomes

  1. The number of pregnant ladies who will have low birth weight babies

    Mothers who will give birth to low birth weight infants

    Time frame: within 2 months

07

Study locations

1 of 1 sites recruiting
  • Algazeerah and Kasralainy hospital
    Giza, Egypt
    • Mahmoud Alalfy, master · Contact · mahmoudalalfy@ymail.com · +201002611058
    • Ahmed Elgazzar, M.D · Contact · +201014005959
    • Mahmoud Alalfy, master · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 9, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03757780
Lead sponsor
Aljazeera Hospital
Collaborators
Kasr El Aini Hospital
Responsible party
Sponsor
First posted
Nov 29, 2018
Start date
Nov 30, 2018
Primary completion
Feb 1, 2019 (estimated)
Completion
Feb 15, 2019 (estimated)
Last update
Jan 9, 2019

Study contacts

Mahmoud Alalfy
Contact
mahmoudalalfy@ymail.com
01002611058
Mahmoud Alalfy
study chair · Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion